5c6f4a28的个人主页 - 老虎社区

5c6f4a28

5c6f4a28

曲直向前，福慧双全！

IP属地：湖北

10关注

1粉丝

0主题

0勋章

2025-01-29

祝福大家新年快乐、万事如意、财源广进[得意][得意][得意]

2024-07-22

伟大的公[强] [强] [强]

@驿山居士:吉利德——一家伟大的公司

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4184569273691130","uuid":"4184569273691130","gmtCreate":1721466139517,"gmtModify":1721654169673,"name":"5c6f4a28","pinyin":"888plxr888888penglaixianren888","introduction":"","introductionEn":"","signature":"曲直向前，福慧双全！","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","hatId":"ca_profile_frame_DWr5S1","hatName":"LV3 头像框","vip":1,"status":2,"fanSize":1,"headSize":10,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.12.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.15","exceedPercentage":"80.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.25","exceedPercentage":"60.57%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"1f74612b6f95455f970edd02b5316db8-3","templateUuid":"1f74612b6f95455f970edd02b5316db8","name":"收益排行","description":"Top 20%","bigImgUrl":"https://static.tigerbbs.com/1ece4391160b811e6f36b1eea9eb6ea4","smallImgUrl":"https://static.tigerbbs.com/7d7540817554a583ac3bf85dea074a4a","grayImgUrl":"https://static.tigerbbs.com/8c5460a7cc80dd22560efa26813d947d","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":1691625600000,"redirectLinkValidityTo":1725062400000,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5300,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"5697d37f217342faaa027fdb5a6e7c12-2","templateUuid":"5697d37f217342faaa027fdb5a6e7c12","name":"单笔平均盈利排行","description":"Top 30%","bigImgUrl":"https://static.tigerbbs.com/7554ebe7d1898f430d98e76f650368cf","smallImgUrl":"https://static.tigerbbs.com/fe4bec6a19cf99388987516558515819","grayImgUrl":"https://static.tigerbbs.com/18dd3e6a5c1a81de02d26eef5a5c7f28","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":1691625600000,"redirectLinkValidityTo":1725062400000,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.07.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5200,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.07.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":7,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"湖北","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":9,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":397685352546432,"gmtCreate":1738113507201,"gmtModify":1738114017292,"author":{"id":"4184569273691130","authorId":"4184569273691130","name":"5c6f4a28","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184569273691130","idStr":"4184569273691130"},"themes":[],"title":"","htmlText":"祝福大家新年快乐、万事如意、财源广进[得意][得意][得意]","listText":"祝福大家新年快乐、万事如意、财源广进[得意][得意][得意]","text":"祝福大家新年快乐、万事如意、财源广进[得意][得意][得意]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/397685352546432","isVote":1,"tweetType":1,"viewCount":2046,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":330214204199104,"gmtCreate":1721649663564,"gmtModify":1721654226175,"author":{"id":"4184569273691130","authorId":"4184569273691130","name":"5c6f4a28","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184569273691130","idStr":"4184569273691130"},"themes":[],"title":"","htmlText":"伟大的公[强]&nbsp;[强]&nbsp;[强]&nbsp;&nbsp;","listText":"伟大的公[强]&nbsp;[强]&nbsp;[强]&nbsp;&nbsp;","text":"伟大的公[强] [强] [强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/330214204199104","repostId":"329823888425208","repostType":1,"repost":{"id":329823888425208,"gmtCreate":1721553882038,"gmtModify":1721564309273,"author":{"id":"4160708798706472","authorId":"4160708798706472","name":"驿山居士","avatar":"https://static.tigerbbs.com/0ffa307ce0fb7e443cf651a9aef97896","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4160708798706472","idStr":"4160708798706472"},"themes":[],"title":"吉利德——一家伟大的公司","htmlText":"‌<a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$ &nbsp;</a>‌ 吉利德，这是一家伟大的公司。 它有望帮助全球终结艾滋病——其新型艾滋病预防药物试验首次实现后期“O感染”，只需要一年两针。 从技术上看，上一次冲击长期压力线时遇阻回撤，短暂修整后于最近两天直接突破压力线。上涨空间正式打开！ 回顾2013年-2015年吉利德的行情，翻了足足6倍。 当时发生了一件事，就是FDA批准了吉利德公司治疗丙肝的新药索非布韦上市。 这种神药一上市，立即横扫市场，干倒了一批丙肝药对手，刺激了口服类药物市场急速扩增。上市第一年，吉一代就以百亿美元的销售额冲上了全球最畅销药物榜单第二名，创造了新药销售史上的神话，至今都无人打破。吉利德不仅一年就接近收回了收购研发企业的成本，还凭此进入全球制药企业TOP 10俱乐部，就此成为丙肝治疗领域当之无愧的霸主。 不过，吉利德并没有“让子弹多飞一会儿”，让吉一代赚更多的钱，而是趁热打铁，在不到一年时间里又推出了“吉二代”，它不仅见效迅速，而且让病人彻底摆脱了干扰素，随后几年，吉利德又一鼓作气推出了“吉三代”“吉四代”丙肝药，覆盖了所有6种基因型丙肝病毒，它们都能迅速阻断靶标病毒，从而根除丙肝。 自此丙肝几乎从地球消失。 是的，吉利德就是如此的伟大。 丙肝消失后，吉利德的丙肝药也退出了历史舞台，吉利德从此失去了一大印钞机。 但是此次吉利德发布的艾滋病疫苗有所不同，它不是一次性疫苗，而是需要每半年打一针——这就意味着一部长期印钞机即将诞生了。 未来能否再次复制当年这种走势，我们拭目以待。 （风险——从实验室走向市场，还有很多路要走）","listText":"‌<a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$ &nbsp;</a>‌ 吉利德，这是一家伟大的公司。 它有望帮助全球终结艾滋病——其新型艾滋病预防药物试验首次实现后期“O感染”，只需要一年两针。 从技术上看，上一次冲击长期压力线时遇阻回撤，短暂修整后于最近两天直接突破压力线。上涨空间正式打开！ 回顾2013年-2015年吉利德的行情，翻了足足6倍。 当时发生了一件事，就是FDA批准了吉利德公司治疗丙肝的新药索非布韦上市。 这种神药一上市，立即横扫市场，干倒了一批丙肝药对手，刺激了口服类药物市场急速扩增。上市第一年，吉一代就以百亿美元的销售额冲上了全球最畅销药物榜单第二名，创造了新药销售史上的神话，至今都无人打破。吉利德不仅一年就接近收回了收购研发企业的成本，还凭此进入全球制药企业TOP 10俱乐部，就此成为丙肝治疗领域当之无愧的霸主。 不过，吉利德并没有“让子弹多飞一会儿”，让吉一代赚更多的钱，而是趁热打铁，在不到一年时间里又推出了“吉二代”，它不仅见效迅速，而且让病人彻底摆脱了干扰素，随后几年，吉利德又一鼓作气推出了“吉三代”“吉四代”丙肝药，覆盖了所有6种基因型丙肝病毒，它们都能迅速阻断靶标病毒，从而根除丙肝。 自此丙肝几乎从地球消失。 是的，吉利德就是如此的伟大。 丙肝消失后，吉利德的丙肝药也退出了历史舞台，吉利德从此失去了一大印钞机。 但是此次吉利德发布的艾滋病疫苗有所不同，它不是一次性疫苗，而是需要每半年打一针——这就意味着一部长期印钞机即将诞生了。 未来能否再次复制当年这种走势，我们拭目以待。 （风险——从实验室走向市场，还有很多路要走）","text":"‌$吉利德科学(GILD)$ ‌ 吉利德，这是一家伟大的公司。 它有望帮助全球终结艾滋病——其新型艾滋病预防药物试验首次实现后期“O感染”，只需要一年两针。 从技术上看，上一次冲击长期压力线时遇阻回撤，短暂修整后于最近两天直接突破压力线。上涨空间正式打开！ 回顾2013年-2015年吉利德的行情，翻了足足6倍。 当时发生了一件事，就是FDA批准了吉利德公司治疗丙肝的新药索非布韦上市。 这种神药一上市，立即横扫市场，干倒了一批丙肝药对手，刺激了口服类药物市场急速扩增。上市第一年，吉一代就以百亿美元的销售额冲上了全球最畅销药物榜单第二名，创造了新药销售史上的神话，至今都无人打破。吉利德不仅一年就接近收回了收购研发企业的成本，还凭此进入全球制药企业TOP 10俱乐部，就此成为丙肝治疗领域当之无愧的霸主。 不过，吉利德并没有“让子弹多飞一会儿”，让吉一代赚更多的钱，而是趁热打铁，在不到一年时间里又推出了“吉二代”，它不仅见效迅速，而且让病人彻底摆脱了干扰素，随后几年，吉利德又一鼓作气推出了“吉三代”“吉四代”丙肝药，覆盖了所有6种基因型丙肝病毒，它们都能迅速阻断靶标病毒，从而根除丙肝。 自此丙肝几乎从地球消失。 是的，吉利德就是如此的伟大。 丙肝消失后，吉利德的丙肝药也退出了历史舞台，吉利德从此失去了一大印钞机。 但是此次吉利德发布的艾滋病疫苗有所不同，它不是一次性疫苗，而是需要每半年打一针——这就意味着一部长期印钞机即将诞生了。 未来能否再次复制当年这种走势，我们拭目以待。 （风险——从实验室走向市场，还有很多路要走）","images":[{"img":"https://static.tigerbbs.com/75d5d638465e412fbdc3e571247bceba","width":"200","height":"200"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/329823888425208","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":330214204199104,"gmtCreate":1721649663564,"gmtModify":1721654226175,"author":{"id":"4184569273691130","authorId":"4184569273691130","name":"5c6f4a28","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4184569273691130","authorIdStr":"4184569273691130"},"themes":[],"title":"","htmlText":"伟大的公[强]&nbsp;[强]&nbsp;[强]&nbsp;&nbsp;","listText":"伟大的公[强]&nbsp;[强]&nbsp;[强]&nbsp;&nbsp;","text":"伟大的公[强] [强] [强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/330214204199104","repostId":"329823888425208","repostType":1,"repost":{"id":329823888425208,"gmtCreate":1721553882038,"gmtModify":1721564309273,"author":{"id":"4160708798706472","authorId":"4160708798706472","name":"驿山居士","avatar":"https://static.tigerbbs.com/0ffa307ce0fb7e443cf651a9aef97896","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4160708798706472","authorIdStr":"4160708798706472"},"themes":[],"title":"吉利德——一家伟大的公司","htmlText":"‌<a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$ &nbsp;</a>‌ 吉利德，这是一家伟大的公司。 它有望帮助全球终结艾滋病——其新型艾滋病预防药物试验首次实现后期“O感染”，只需要一年两针。 从技术上看，上一次冲击长期压力线时遇阻回撤，短暂修整后于最近两天直接突破压力线。上涨空间正式打开！ 回顾2013年-2015年吉利德的行情，翻了足足6倍。 当时发生了一件事，就是FDA批准了吉利德公司治疗丙肝的新药索非布韦上市。 这种神药一上市，立即横扫市场，干倒了一批丙肝药对手，刺激了口服类药物市场急速扩增。上市第一年，吉一代就以百亿美元的销售额冲上了全球最畅销药物榜单第二名，创造了新药销售史上的神话，至今都无人打破。吉利德不仅一年就接近收回了收购研发企业的成本，还凭此进入全球制药企业TOP 10俱乐部，就此成为丙肝治疗领域当之无愧的霸主。 不过，吉利德并没有“让子弹多飞一会儿”，让吉一代赚更多的钱，而是趁热打铁，在不到一年时间里又推出了“吉二代”，它不仅见效迅速，而且让病人彻底摆脱了干扰素，随后几年，吉利德又一鼓作气推出了“吉三代”“吉四代”丙肝药，覆盖了所有6种基因型丙肝病毒，它们都能迅速阻断靶标病毒，从而根除丙肝。 自此丙肝几乎从地球消失。 是的，吉利德就是如此的伟大。 丙肝消失后，吉利德的丙肝药也退出了历史舞台，吉利德从此失去了一大印钞机。 但是此次吉利德发布的艾滋病疫苗有所不同，它不是一次性疫苗，而是需要每半年打一针——这就意味着一部长期印钞机即将诞生了。 未来能否再次复制当年这种走势，我们拭目以待。 （风险——从实验室走向市场，还有很多路要走）","listText":"‌<a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$ &nbsp;</a>‌ 吉利德，这是一家伟大的公司。 它有望帮助全球终结艾滋病——其新型艾滋病预防药物试验首次实现后期“O感染”，只需要一年两针。 从技术上看，上一次冲击长期压力线时遇阻回撤，短暂修整后于最近两天直接突破压力线。上涨空间正式打开！ 回顾2013年-2015年吉利德的行情，翻了足足6倍。 当时发生了一件事，就是FDA批准了吉利德公司治疗丙肝的新药索非布韦上市。 这种神药一上市，立即横扫市场，干倒了一批丙肝药对手，刺激了口服类药物市场急速扩增。上市第一年，吉一代就以百亿美元的销售额冲上了全球最畅销药物榜单第二名，创造了新药销售史上的神话，至今都无人打破。吉利德不仅一年就接近收回了收购研发企业的成本，还凭此进入全球制药企业TOP 10俱乐部，就此成为丙肝治疗领域当之无愧的霸主。 不过，吉利德并没有“让子弹多飞一会儿”，让吉一代赚更多的钱，而是趁热打铁，在不到一年时间里又推出了“吉二代”，它不仅见效迅速，而且让病人彻底摆脱了干扰素，随后几年，吉利德又一鼓作气推出了“吉三代”“吉四代”丙肝药，覆盖了所有6种基因型丙肝病毒，它们都能迅速阻断靶标病毒，从而根除丙肝。 自此丙肝几乎从地球消失。 是的，吉利德就是如此的伟大。 丙肝消失后，吉利德的丙肝药也退出了历史舞台，吉利德从此失去了一大印钞机。 但是此次吉利德发布的艾滋病疫苗有所不同，它不是一次性疫苗，而是需要每半年打一针——这就意味着一部长期印钞机即将诞生了。 未来能否再次复制当年这种走势，我们拭目以待。 （风险——从实验室走向市场，还有很多路要走）","text":"‌$吉利德科学(GILD)$ ‌ 吉利德，这是一家伟大的公司。 它有望帮助全球终结艾滋病——其新型艾滋病预防药物试验首次实现后期“O感染”，只需要一年两针。 从技术上看，上一次冲击长期压力线时遇阻回撤，短暂修整后于最近两天直接突破压力线。上涨空间正式打开！ 回顾2013年-2015年吉利德的行情，翻了足足6倍。 当时发生了一件事，就是FDA批准了吉利德公司治疗丙肝的新药索非布韦上市。 这种神药一上市，立即横扫市场，干倒了一批丙肝药对手，刺激了口服类药物市场急速扩增。上市第一年，吉一代就以百亿美元的销售额冲上了全球最畅销药物榜单第二名，创造了新药销售史上的神话，至今都无人打破。吉利德不仅一年就接近收回了收购研发企业的成本，还凭此进入全球制药企业TOP 10俱乐部，就此成为丙肝治疗领域当之无愧的霸主。 不过，吉利德并没有“让子弹多飞一会儿”，让吉一代赚更多的钱，而是趁热打铁，在不到一年时间里又推出了“吉二代”，它不仅见效迅速，而且让病人彻底摆脱了干扰素，随后几年，吉利德又一鼓作气推出了“吉三代”“吉四代”丙肝药，覆盖了所有6种基因型丙肝病毒，它们都能迅速阻断靶标病毒，从而根除丙肝。 自此丙肝几乎从地球消失。 是的，吉利德就是如此的伟大。 丙肝消失后，吉利德的丙肝药也退出了历史舞台，吉利德从此失去了一大印钞机。 但是此次吉利德发布的艾滋病疫苗有所不同，它不是一次性疫苗，而是需要每半年打一针——这就意味着一部长期印钞机即将诞生了。 未来能否再次复制当年这种走势，我们拭目以待。 （风险——从实验室走向市场，还有很多路要走）","images":[{"img":"https://static.tigerbbs.com/75d5d638465e412fbdc3e571247bceba","width":"200","height":"200"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/329823888425208","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":397685352546432,"gmtCreate":1738113507201,"gmtModify":1738114017292,"author":{"id":"4184569273691130","authorId":"4184569273691130","name":"5c6f4a28","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4184569273691130","authorIdStr":"4184569273691130"},"themes":[],"title":"","htmlText":"祝福大家新年快乐、万事如意、财源广进[得意][得意][得意]","listText":"祝福大家新年快乐、万事如意、财源广进[得意][得意][得意]","text":"祝福大家新年快乐、万事如意、财源广进[得意][得意][得意]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/397685352546432","isVote":1,"tweetType":1,"viewCount":2046,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}